Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
SUSANNA GATTI HIGH Insider Profile
4 Followers
SUSANNA GATTI HIGH, COO at Bluebird Bio, holds 131.64K shares in Dyne Therapeutics (Ticker: DYN), holds 13.73K shares in Bluebird Bio (Ticker: BLUE).
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+17.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by SUSANNA GATTI HIGH
SUSANNA GATTI HIGH's Trading History
Bluebird Bio
Dec 10, 2018
COO
Uninformative Sell
198.19K
$5.56K
Dyne Therapeutics
Sep 19, 2024
COO
Uninformative Sell
308.86K
$3.75M
List of latest transactions for each holding click on a transaction to see SUSANNA GATTI HIGH's performance on stock
You May Also Like
SUSANNA GATTI HIGH insider profile FAQ
What is the percentage of profitable transactions made by SUSANNA GATTI HIGH?
The percentage of profitable transactions made by SUSANNA GATTI HIGH is 67%.
What is the average return per transaction made by SUSANNA GATTI HIGH?
The average return per transaction made by SUSANNA GATTI HIGH is 17.90%.
What stocks does SUSANNA GATTI HIGH hold?
SUSANNA GATTI HIGH holds: BLUE, DYN stocks.
What was SUSANNA GATTI HIGH’s latest transaction?
SUSANNA GATTI HIGH latest transaction was an Uninformative Sell of $308.86K.
What was SUSANNA GATTI HIGH's most profitable transaction?
SUSANNA GATTI HIGH’s most profitable transaction was an Informative Sell of BLUE stock on December 5, 2017. The return on the trade was 30.10%.
What is SUSANNA GATTI HIGH's role in Bluebird Bio?
SUSANNA GATTI HIGH's role in Bluebird Bio is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.